Polyarticular septic arthritis due to Moraxella canis revealing multiple myeloma.
Ottaviani
Sébastien
S
Kemiche
Farid
F
Thibault
Michel
M
Cerf-Payrastre
Isabelle
I
Pertuiset
Edouard
E
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000382:microbiology* / Q000473:pathology; D002439:Cefotaxime / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004199:Disease Vectors; D004283:Dog Diseases / Q000382:microbiology / Q000635:transmission; D004285:Dogs; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009016:Moraxella / Q000302:isolation & purification / Q000472:pathogenicity*; D045828:Moraxellaceae Infections / Q000150:complications* / Q000473:pathology; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000276:immunology* / Q000628:therapy; D015242:Ofloxacin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D015242:Ofloxacin; D002439:Cefotaxime